Literature DB >> 2835296

The problem of identification of prognostic factors for persistent trophoblastic disease.

F Parazzini1, G Mangili, C Belloni, C La Vecchia, P Liati, R Marabini.   

Abstract

The role of anamnestic and clinical factors in defining the high group at risk of developing persistent trophoblastic disease (PTD) has been analyzed in 301 cases of hydatidiform mole. Patients age 40 or more years with AB blood, and a previous history of molar pregnancy had an elevated risk of developing PTD. The presence of various risk factors increased the frequency of PTD. However, with discriminant analysis, correct classification of outcome was obtained for only 69% of cases. Despite the magnitude of risk of PTD for women with three or more risk factors, the clinical relevance of prognostic variables in the prediction of outcome was limited by the low proportion of women classified in the low- and high-risk groups, making the identification at diagnosis of the women who could benefit of prophylactic chemotherapy extremely difficult and hence of little clinical importance.

Entities:  

Mesh:

Substances:

Year:  1988        PMID: 2835296     DOI: 10.1016/0090-8258(88)90046-7

Source DB:  PubMed          Journal:  Gynecol Oncol        ISSN: 0090-8258            Impact factor:   5.482


  5 in total

1.  Expression of epidermal growth factor receptor in gestational trophoblastic diseases.

Authors:  P Balaram; M John; T N Rajalekshmy; B Nair; G Schultz; K Nair
Journal:  J Cancer Res Clin Oncol       Date:  1997       Impact factor: 4.553

2.  Expression of c-erbB2 in gestational trophoblastic disease and its clinical significance.

Authors:  Yuxia Wang; Yang Cao; Yongyu Sun
Journal:  J Huazhong Univ Sci Technolog Med Sci       Date:  2002

Review 3.  Gestational trophoblastic neoplasia in the 1990s.

Authors:  D P Goldstein
Journal:  Yale J Biol Med       Date:  1991 Nov-Dec

4.  Complementary Role of Ultrasound in Management of Gestational Trophoblastic Disease.

Authors:  Mahrooz Malek; Behnaz Moradi; Azam Sadat Mousavi; Nasrin Ahmadinejad; Mohamad Ali Kazemi; Masoumeh Gity
Journal:  Iran J Radiol       Date:  2015-02-07       Impact factor: 0.212

5.  Siglec-6 is expressed in gestational trophoblastic disease and affects proliferation, apoptosis and invasion.

Authors:  Kristen K Rumer; Miriam D Post; Rhea S Larivee; Martina Zink; Jill Uyenishi; Anita Kramer; Deanna Teoh; Kevin Bogart; Virginia D Winn
Journal:  Endocr Relat Cancer       Date:  2012-11-19       Impact factor: 5.678

  5 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.